A2 BiotherapeuticsListed
a2biotherapeutics.combiotech_life_sciences
A2 Biotherapeutics is advancing its Tmod™ cell engineering platform to create precision CAR T-cell therapies, focusing on restoring health and hope for patients with cancer and ot…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
A2 Biotherapeutics is advancing its Tmod™ cell engineering platform to create precision CAR T-cell therapies, focusing on restoring health and hope for patients with cancer and ot…
Adcendo ApS is a clinical-stage biotech company focused on developing first- and best-in-class antibody-drug conjugates (ADCs) for the treatment of cancers with high unmet medical…
Aktis Oncology is committed to improving outcomes for cancer patients by pioneering a new class of targeted radiopharmaceuticals addressing prevalent tumor types that historically…
Allogene Therapeutics is a clinical-stage biotechnology company focused on pioneering the development of investigational allogeneic chimeric antigen receptor T cell (AlloCAR T) pr…
Alterome is a clinical-stage biotechnology company focused on developing targeted therapies for cancer, utilizing structure-guided drug discovery and precision oncology.
Antares Therapeutics is a biotechnology company developing transformational, first-in-class precision medicines with a focus on validated, undruggable targets in cancer and other…
Asklepios BioPharmaceutical focuses on the development of gene therapies for rare diseases and other serious conditions.
Attovia Therapeutics is a clinical-stage biopharmaceutical company focused on immune-mediated diseases, developing next-generation biologic therapies using its proprietary ATTOBOD…
Avalyn is a clinical-stage biotech company developing inhaled therapies to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.
Candid Therapeutics is a biotech company focused on developing treatments for fungal infections.
Capstan Therapeutics is focused on in vivo engineering of cells through targeted lipid nanoparticles, aiming to address complex health issues and enhance people's lives.
Centessa Pharmaceuticals is focused on discovering and developing transformational medicines for patients, particularly in the field of neuroscience. They aim to address high unme…
A biotechnology company developing nucleic acid therapies for rare diseases.
Halda Therapeutics is a biotech company focused on developing innovative treatments.
InduPro specializes in proximity-based therapeutics, focusing on the spatial relationships of proteins on cell surfaces to develop innovative drug therapies.
Kronos Bio is a clinical-stage biopharmaceutical company developing therapeutics that target the dysregulated transcription that causes cancer and other serious diseases. The comp…
Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. Their lead CAR T-cell…
LB Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric dise…
Neogene Therapeutics is a global, clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR)…
Peloton Therapeutics is a biotechnology company focused on developing innovative therapies for cancer treatment through its proprietary drug discovery platform.
Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing com…
Protego Biopharma is a clinical-stage biotechnology company dedicated to pioneering first-in-class small molecule therapeutics that reprogram protein folding to address systemic a…
Quanta Therapeutics is a private biopharmaceutical company focused on developing innovative oral therapeutics for RAS-driven cancers, particularly through the use of allosteric in…
ReCode Therapeutics is developing therapeutics for genetically defined diseases with no existing treatment options, including cystic fibrosis and primary ciliary dyskinesia, using…
Scorpion is a clinical-stage, precision oncology company developing transformational targeted therapies for patients with cancer. We have built proprietary and fully-integrated di…
Soufflé Therapeutics is a biotechnology company developing cell-specific small interfering RNA (siRNA) medicines for a range of diseases.
Tectonic is a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-Protein Coupled…
Third Arc Bio is innovating antibody therapeutics by developing multifunctional antibodies that engage multiple targets and cell types, focusing on oncology and immunology.
Vigil Neuroscience is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases by targeting microglial biology and neuroinflammation.
Volastra is an NYC-based clinical stage biotechnology company dedicated to the discovery and development of oncology therapeutics targeting chromosomal instability, or CIN, a key…
SonoThera is dedicated to developing the next generation of genetic medicines using a proprietary, non-invasive ultrasound-mediated delivery approach that enables broad, highly ta…
Poplar Therapeutics is a clinical-stage immunology company developing a new class of anti-IgE therapy to challenge convention in allergic disease treatment. Its lead program, PHB-…